PRODUCTS
APIs and intermediates
No data

No data

  • (S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
  • (S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
  • (S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
  • (S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
  • (S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine
+

Share

(S)-1-(4-phenyl-1H-imidazol-2-yl)ethanamine



Summary:

As a mu opioid receptor agonist, aishadurin acts on mu opioid receptor, so as to play a role in the treatment of diarrhea irritable bowel syndrome (IBS-D). It is the first oral effective and local therapeutic drug with a unique mechanism of action

CAS:

864825-23-0

Standard:

ISO9001/14001/18001, Purity 99%

Purity:


Keywords:

API and Intermediates

  • Product description
  • As a mu opioid receptor agonist, aishadurin acts on mu opioid receptor, so as to play a role in the treatment of diarrhea irritable bowel syndrome (IBS-D). It is the first oral effective and local therapeutic drug with a unique mechanism of action; The drug has mixed opioid receptor activity and is μ Receptor antagonists are also delta opioid receptor agonists and kappa receptor agonists. Taking drugs while eating can significantly reduce the symptoms of abdominal pain and diarrhea in IBS-D patients. Irritable bowel syndrome (IBS) is a common gastrointestinal disease, and aisadoulin is a mixed drug μ Receptor agonists δ Receptor antagonists κ Receptor agonists for the remission of diarrhea irritable bowel syndrome (IBS-D). Studies have shown that isadolin can significantly improve the clinical symptoms of IBS-D patients, with good tolerance and less adverse reactions.

Messages

Note: Please provide accurate and detailed information, and our professional staff will contact you as soon as possible!

Recommended products